Park Do Hwi, Han Byungcheol, Shin Myoung-Sook, Hwang Gwi Seo
College of Korean Medicine, Gachon University, Seongnam-si, Gyeonggi-do 13120, Korea.
Efficacy & Safety Team, Korea Ginseng Corp., 30, Gajeong-ro, Yuseong-gu, Daejeon 34128, Korea.
Polymers (Basel). 2020 Sep 24;12(10):2186. doi: 10.3390/polym12102186.
(1) Background: The immunostimulatory role of the polysaccharide fraction (KRG-P) of Korea red ginseng (KRG) was studied in cells. However, its immunomodulatory activity is unknown. Therefore, we investigated the chemical properties of KRG-P and its intestinal immune responses in vitro and in vivo. (2) Methods: KRG-P monosaccharide composition and molecular weight were determined using high-performance liquid and size-exclusion chromatography systems. Immunoglobulin A (IgA) and α-defensin-1 transcript levels were measured using a SYBR Green qRT-PCR; defensin-1, Granulocyte-macrophage colony-stimulating factor (GM-CSF), and IgA protein levels were determined using Western blotting and ELISA kits. (3) Results: The molecular weight of KRG-P was estimated to be 106 kDa, and it contained neutral sugar (74.3%), uronic acid (24.6%), and proteins (1%). In vitro studies of intestinal immunomodulatory activity of KRG-P indicated that GM-CSF and IgA levels increased in Peyer's patch cells to higher levels than those obtained with KRG and induced bone marrow cell proliferation. In in vivo study, oral KRG-P administration to mice upregulated the expression of α-defensin-1 and IgA in the small intestinal tissue and that of secreted IgA in the feces. (4) Conclusions: KRG-P contributed to the modulation of intestinal immunity and maintenance of intestinal homeostasis against intestinal infection.
(1) 背景:研究了高丽红参(KRG)多糖组分(KRG-P)在细胞中的免疫刺激作用。然而,其免疫调节活性尚不清楚。因此,我们研究了KRG-P的化学性质及其在体外和体内的肠道免疫反应。(2) 方法:使用高效液相色谱和尺寸排阻色谱系统测定KRG-P的单糖组成和分子量。使用SYBR Green qRT-PCR测量免疫球蛋白A(IgA)和α-防御素-1转录水平;使用蛋白质免疫印迹法和ELISA试剂盒测定防御素-1、粒细胞-巨噬细胞集落刺激因子(GM-CSF)和IgA蛋白水平。(3) 结果:KRG-P的分子量估计为106 kDa,含有中性糖(74.3%)、糖醛酸(24.6%)和蛋白质(1%)。KRG-P肠道免疫调节活性的体外研究表明,派尔集合淋巴结细胞中的GM-CSF和IgA水平升高,高于KRG处理组,并诱导骨髓细胞增殖。在体内研究中,给小鼠口服KRG-P可上调小肠组织中α-防御素-1和IgA的表达以及粪便中分泌型IgA的表达。(4) 结论:KRG-P有助于调节肠道免疫并维持肠道内环境稳定以抵抗肠道感染。